Product Information

Pemirolast is a pyridopyrimidine.

CAS No.	69372-19-6
Product Name	Pemirolast

Associated Conditions

Abdominal Aortic Aneurysm·Becker muscular dystrophy·Duchenne muscular dystrophy·asthma

* The information provided here is compiled from public sources and is for reference only.

Studies related to this compound and its mechanism of action

Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.

Biological & pharmaceutical bulletin • Vol. 28, Issue 3 • 2005

PMID: 15744071 DOI: 10.1248/bpb.28.473

Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats.

Neuropharmacology • Vol. 46, Issue 6 • 2004

PMID: 15033348 DOI: 10.1016/j.neuropharm.2003.11.018

A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics • Vol. 20, Issue 2 • 2004

PMID: 15117570 DOI: 10.1089/108076804773710812

Acute asthma attack caused by ophthalmic application of antiallergic agents.

Japanese journal of ophthalmology • Vol. 48, Issue 5 • 2004

PMID: 15486771 DOI: 10.1007/s10384-004-0091-x

Pemirolast

CAS No.	69372-19-6
MDL No.	N/A
MF	C₁₀H₈N₆O
MW	228.21
InChI Key	HIANJWSAHKJQTH-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Pemirolast is a pyridopyrimidine.

CAS No.	69372-19-6
Product Name	Pemirolast

Associated Conditions

Abdominal Aortic Aneurysm·Becker muscular dystrophy·Duchenne muscular dystrophy·asthma

* The information provided here is compiled from public sources and is for reference only.

Pemirolast

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Pemirolast

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Documentation

Pemirolast

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Related Articles

Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.

Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats.

A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis.

Acute asthma attack caused by ophthalmic application of antiallergic agents.

Pemirolast

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Related Articles

Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.

Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats.

A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis.

Acute asthma attack caused by ophthalmic application of antiallergic agents.

Documentation